The Innovation Institute

What The Innovation Institute does

The Innovation Institute, now operating as Inneo, is a healthcare innovation engine established in 2013 and headquartered in Brea, California. The company is collectively owned by six Member-Owner health systems and operates three integrated divisions: Inneo Lab (product development and commercialization), Inneo Alliance (strategic services for health systems), and Inneo Invest (healthcare venture investments). Inneo Lab has commercialized 25 products generating over $25M in portfolio value, with notable products including LiveBand BFR (blood flow restriction technology for rehabilitation and sports medicine) and Move-D (an upper extremity pediatric orthopedic brace). The company leverages a nationwide clinical network to identify pain points, validate market viability, refine product design, and commercialize innovations in partnership with clinicians and health systems.

Inneo Alliance provides strategic services to health systems including cybersecurity, pharmacy solutions, and document management, with documented outcomes including $36M in annualized patient benefits from a patient assistance program with FMOLHS, 30%+ average cybersecurity savings identified for health system networks, and $3.5M in document management savings. Inneo Invest has deployed $40M+ across 60+ health-tech startups through venture funds (Sandbox Blue Venture Fund) and healthcare real estate vehicles (LRV Health Fund), supporting 30,000+ points of care. Inneo is privately held and is not venture capital-backed or publicly traded; the Member-Owner health systems collectively govern the organization. The company recently rebranded from The Innovation Institute to Inneo to reflect its evolving business model.

Name

The Innovation Institute

Legal name

Inneo

Website

https://ii4change.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Inneo (formerly The Innovation Institute) is a healthcare innovation engine collectively owned by six Member-Owner health systems, operating three divisions—Inneo Lab (product commercialization), Inneo Alliance (strategic services), and Inneo Invest (venture investments)—serving health systems across the United States.

Ownership category

akta.pro rank

Product category

Healthcare Innovation Services

NAICS

Computer Systems Design Services (541512)

SIC

Services-Management Consulting Services (8742), Services-Computer Integrated Systems Design (7373)

akta.pro primary industry

Strategy & IT Advisory (BPAEAAAA)

akta.pro secondary industry

Enterprise Architecture & IT Operating Model (BPAHAEAB)

Keywords

• Healthcare innovation services
• Medical device development
• Health system partnerships
• Healthcare venture investing
• Clinical innovation platform

Headquarters

HQ city

La Palma

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Innovation Lab - Product Development & Commercialization: Generates revenue through developing and commercializing healthcare products in partnership with clinicians and health networks. Products include medical devices and health-tech solutions that are brought to market.
2. Alliance Strategic Services: Provides strategic consulting and operational services to health systems including cybersecurity offerings, pharmacy solutions, and document management services. Generates revenue through service fees and cost-sharing arrangements with Member-Owner health systems.
3. Venture Investments: Invests in healthcare technology startups through venture funds and real estate investment vehicles, generating returns through portfolio company success and exits.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

The Innovation Institute (now operating as Inneo) is a healthcare innovation engine that operates three integrated divisions: Inneo Lab (product development and commercialization in collaboration with clinicians and health networks), Inneo Alliance (strategic initiative planning and execution services for health systems, including cybersecurity, pharmacy, and document management), and Inneo Invest (venture investments in health-tech startups and healthcare real estate). It has commercialized 25 products, created over $25M in portfolio value, and invested more than $40M in digital and medical device innovation.

Product overview

Inneo (formerly The Innovation Institute) operates as a healthcare innovation ecosystem consisting of three integrated platforms: Inneo Lab (product development and commercialization), Inneo Alliance (strategic initiatives and support services), and Inneo Invest (venture investment). Inneo Lab has commercialized 25 products generating over $25M in portfolio value, including LiveBand™ BFR for blood flow restriction therapy and Move-D™ brace for pediatric orthopedic care. Inneo Alliance provides cybersecurity and pharmacy services to member health systems. Inneo Invest has deployed over $40M across 60+ health-tech startups supporting 30,000+ points of care. The company is owned by 6 member health systems and serves the broader healthcare landscape through its collective partnership model.

Differentiator

Problem solved

Functional benefit

Brands

• Inneo Lab: Innovation laboratory focused on product development and commercialization, having successfully commercialized 25 products and created over $25M in portfolio value.
• Inneo Alliance
• Inneo Invest

Products and services

• Inneo Lab Healthcare innovation platform that supports product development and commercialization through collaboration with clinicians and health networks, having successfully commercialized 25 products and generating over $25M in portfolio value.
• Innovation as a Service (IaaS) Provides health systems with access to Inneo's innovation capabilities, clinical network, and commercialization expertise on a service basis, translating healthcare ideas into transformative products.
• Inneo Alliance Partnership platform that supports health systems in envisioning, planning, and executing key strategic initiatives across care-critical areas including cybersecurity, pharmacy, and document management services such as the 'Print as a Strategy' offering.
• Inneo Invest Healthcare investment vehicle that blends involvement in several healthcare-oriented venture funds (including the Sandbox Blue Venture Fund and LRV Health Fund) alongside healthcare real estate investment vehicles, with over $40M invested and 60+ health-tech startups in portfolio.
• LiveBand™ BFR Blood flow restriction (BFR) training technology offering breakthrough solutions for strength training and rehabilitation, commercialized through Inneo Lab and distributed through national purchasing agreements and strategic partnerships such as with Performance Health.
• Move-D™ Brace Innovative upper extremity pediatric orthopedic brace developed through Inneo Lab in partnership with OrthoPediatrics Specialty Bracing Division (OPSB) to advance pediatric orthopedic care.

Quantifiable outcome

• 25 products successfully commercialized through Inneo Lab
• +5 more outcomes

Named customers4 records

Segments1 record

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core.

• Valley Children's HealthcarecoreStrategic or Co-development Partner · 3 April 2026Co-development of cybersecurity offering that identified 30%+ average savings for health system networks; participant in Print as a Strategy collaboration saving $3.5M; partner in developing nation's largest pediatric hospital-based renewable energy microgrid expected to cover 80% of energy needs
• Franciscan Missionaries of our Lady Health System (FMOLHS)coreStrategic or Co-development PartnerMember-Owner health system benefiting from patient assistance program collaboration providing $36M in annualized patient benefit; participant in Print as a Strategy collaboration saving $3.5M on document management
• Performance HealthcoreStrategic or Co-development PartnerStrategic partnership to expand access to evidence-based blood flow restriction training solutions (LiveBand BFR) across rehabilitation and sports medicine markets
• OrthoPediatrics Specialty Bracing (OPSB)coreStrategic or Co-development PartnerStrategic partnership to bring Move-D upper extremity pediatric brace to market, advancing pediatric orthopedic care
• Advantus Health PartnerscoreChannel Partner/ Reseller/ DistributorNational purchasing agreement for LiveBand BFR blood flow restriction technology, distributing the product through Advantus's comprehensive supply chain solutions
• Rady Children's Hospital - Orange CountycoreStrategic or Co-development PartnerActive partnership with Inneo Lab for deeply embedded, broadly engaged innovation collaboration in pediatric healthcare

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Cleveland Clinic Innovations: Cleveland Clinic's commercialization arm develops and spins out medical devices and healthtech from clinician-led insights. Most direct comparable to Inneo Lab's product commercialization model with embedded hospital-system support.
• Mayo Clinic Platform: Mayo's health-system-affiliated innovation engine curates clinical data, develops digital health solutions, and partners with industry. Comparable to Inneo in combining clinician-led product development with external partnership monetization.
• Mass General Brigham Innovation: Innovation and commercialization arm of a major U.S. academic health system that develops and licenses medical technologies and startups. Directly comparable to Inneo Lab's clinician-led commercialization approach.
• Cedars-Sinai Accelerator: Cedars-Sinai runs a health-tech accelerator and innovation ecosystem for health system-derived products and partnerships. Comparable to Inneo Lab's product development plus Inneo Invest's venture exposure.
• Kaiser Permanente Ventures: The corporate venture arm of Kaiser Permanente, investing in healthcare technology companies with strategic alignment to a major health system. Comparable to Inneo Invest's venture deployment model.
• NewYork-Presbyterian Ventures: The strategic investment and innovation arm of NYP, backing healthtech and digital health ventures. Comparable to Inneo Invest given its hospital-system-affiliated venture model.

Broad incumbents

• AVIA Health Innovation: Healthcare innovation consulting firm that partners with health systems on digital transformation and innovation strategy. Comparable to Inneo Alliance's strategic services for health systems, though broader in scope.

Emerging players

• Healthbox: Healthcare innovation advisory and accelerator firm that works with health systems on innovation strategy and venture sourcing. Comparable to a scaled-down version of Inneo's Alliance + Lab combination.

Market position

Strengths1 record

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/the-innovation-institute
• Xx.com/ii4change
• Facebookfacebook.com/the.innovation.institute

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Innovation Institute